NCT01649661View on ClinicalTrials.gov

MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk

CompletedOBSERVATIONAL
Enrollment

437

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

January 25, 2023

Study Completion Date

January 25, 2023

Conditions
Cancer Free Women
Interventions
BEHAVIORAL

questionnaire

Trial Locations (1)

10021

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

University of Southern California

OTHER

collaborator

University of Toronto

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT01649661 - MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk | Biotech Hunter | Biotech Hunter